Ensign Peak Advisors’s Atea Pharmaceuticals AVIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-84,030
| Closed | -$314K | – | 1756 |
|
|
2023
Q2 | $314K | Buy |
84,030
+15,550
| +23% | +$58.2K | ﹤0.01% | 1708 |
|
|
2023
Q1 | $229K | Buy |
68,480
+19,500
| +40% | +$65.3K | ﹤0.01% | 1735 |
|
|
2022
Q4 | $236K | Buy |
48,980
+19,200
| +64% | +$92.4K | ﹤0.01% | 1733 |
|
|
2022
Q3 | $169K | Hold |
29,780
| – | – | ﹤0.01% | 1932 |
|
|
2022
Q2 | $211K | Hold |
29,780
| – | – | ﹤0.01% | 1778 |
|
|
2022
Q1 | $215K | Hold |
29,780
| – | – | ﹤0.01% | 1861 |
|
|
2021
Q4 | $266K | Buy |
+29,780
| New | +$266K | ﹤0.01% | 1852 |
|